Oaktree Acquisition Corp. III Life Sciences (OACC)
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Sector: Blank Checks
Industry: Shell Companies
Oaktree Acquisition Corp. II
NASDAQ:OACCFinancial Services · Shell Companies
+0.19%$10.71
Mkt Cap$211.88M
Float19.78M
O/S19.78M
Inst Own89.4%
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income$7.29M
Total Assets$203.11M
Free Cash Flow-$422K
Debt & Equity
Debt 0%
Equity 100%
Total Debt$12K
Total Equity$194.79M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in OACC's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$203.11M
Liabilities$8.32M
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 |
| Revenue | $0 | $0 |
| YoY Growth | - | - |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Gross Margin | - | - |
| Research and Development | $0 | $0 |
| Selling, General, and Administrative | $1.2M | $704 |
| Other | $0 | $0 |
| Total Operating Expenses | $1.2M | $704 |
| Operating Income (EBIT) | -$1.2M | -$703 |
| Operating Margin | - | - |
| Interest Expense | $0 | $0 |
| Interest Income | $8.48M | $1.59M |
| Other Income (Expense) | $8.48M | $3K |
| Income Before Tax (EBT) | $7.29M | $3K |
| Income Tax Expense | $0 | $0 |
| Net Income | $7.29M | $3K |
| Net Income Margin | - | - |
| Supplementary Data | ||
| EPS | 0.30 | 0.05 |
| Diluted EPS | 0.30 | 0.05 |
| Weighted Average OS | 19.20M | 24.58M |
| EBITDA | -$1.2M | $703K |
| EBITDA Margin | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 |
| Assets | ||
| Current Assets | ||
| Cash and Cash Equivalents | $1.43M | $1.36M |
| Short-Term Investments | $0 | $0 |
| Cash and Short-Term Investments | $1.43M | $1.36M |
| Accounts Receivable | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current Assets | $0 | $0 |
| Total Current Assets | $1.55M | $1.56M |
| Long-Term Assets | ||
| Property, Plant & Equipment Net | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangible Assets | $0 | $0 |
| Long-Term Investments | $201.56M | $193.58M |
| Deferred Tax Assets | $0 | $0 |
| Other Long-Term Assets | $0 | $113K |
| Total Long-Term Assets | $201.56M | $193.69M |
| Other Assets | $0 | $0 |
| Total Assets | $203.11M | $195.25M |
| Liabilities | ||
| Current Liabilities | ||
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $12K | $12K |
| Current Income Tax Payable | $0 | $0 |
| Current Unearned Revenue | $0 | $0 |
| Other Current Liabilities | $1.29M | $180K |
| Total Current Liabilities | $1.3M | $727K |
| Long-Term Liabilities | ||
| Long-Term Debt | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 |
| Other Long-Term Liabilities | $7.02M | $7.02M |
| Total Long-Term Liabilities | $7.02M | $7.02M |
| Other Liabilities | $0 | $0 |
| Total Liabilities | $8.32M | $7.75M |
| Stockholders' Equity | ||
| Preferred Stock | $0 | $0 |
| Common Stock | $201.56M | $193.58M |
| Retained Earnings | -$6.77M | -$6.08M |
| Comprehensive Income & Other | $0 | $0 |
| Other Stockholders' Equity | $0 | $0 |
| Total Equity | $194.79M | $187.5M |
| Minority Interest | $0 | $0 |
| Total Liabilities and Equity | $203.11M | $195.25M |
| Supplementary Data | ||
| Total Debt | $12K | $12K |
| Net Debt | -$1.42M | -$1.35M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 |
|---|---|---|
| Currency | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 |
| Operating Activities | ||
| Net Income | $7.29M | $3K |
| Depreciation & Amortization | $0 | $704K |
| Deferred Income Tax | $0 | $0 |
| Stock-Based Compensation | $0 | $0 |
| Changes in Working Capital: | ||
| Accounts Receivable | $0 | $0 |
| Inventory | $0 | $0 |
| Accounts Payable | -$34K | $0 |
| Other Working Capital | $807K | -$629 |
| Total Working Capital Change | $774K | -$629 |
| Other Non-Cash Items | -$8.48M | -$795K |
| Net Cash from Operating | -$422K | -$90K |
| Investing Activities | ||
| Capital Expenditures | $0 | $0 |
| Acquisitions | $0 | $0 |
| Purchases of Investments | $0 | -$191.99M |
| Sales of Investments | $0 | $0 |
| Other Investing Activities | $500K | $0 |
| Net Cash from Investing | $500K | -$191.99M |
| Financing Activities | ||
| Debt Repaid | - | - |
| Common Stock Issuance | $0 | $193.99M |
| Common Stock Repurchases | $0 | $0 |
| Dividends Paid | $0 | $0 |
| Other Financing Activities | $0 | $0 |
| Net Cash from Financing | $0 | $193.44M |
| Forex Effect | $0 | $0 |
| Net Change in Cash | $78K | $1.36M |
| Supplementary Data | ||
| Operating Cash Flow | -$422K | -$179 |
| Capital Expenditure | $0 | -$3 |
| Free Cash Flow | -$422K | -$179 |
| Cash at Beginning | $1.36M | $0 |
| Cash at End | $1.43M | $1.36M |